Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain.
Antonio Solana-AltabellaBlanca BoludaRebeca Rodríguez-VeigaIsabel CanoEvelyn Acuña-CruzAlbert BlancoJavier Marco-AyalaRosalía de la PuertaÁlvaro Díaz-GonzálezJosé L PiñanaJaime SanzAmparo SempereJosé CerveraEva BarragánClaudia SargasOctavio Ballesta-LópezJuan Eduardo Megías-VericatDavid Martínez-CuadrónMiguel Á SanzPau MontesinosPublished in: European journal of haematology (2021)
Data from this study suggest that there is a substantial healthcare resource utilization and cost burden on R/R FLT3mut AML patients in Spain receiving active treatments.
Keyphrases
- acute myeloid leukemia
- healthcare
- allogeneic hematopoietic stem cell transplantation
- end stage renal disease
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- tyrosine kinase
- patient reported outcomes
- electronic health record
- big data
- risk factors
- diffuse large b cell lymphoma
- hodgkin lymphoma
- data analysis